Enhancement of paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrine
- 1 June 1997
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 75 (11) , 1593-1600
- https://doi.org/10.1038/bjc.1997.272
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Suppression of various human tumor cell lines by a dominant negative H-ras mutant.1994
- Regulation of intracellular actin polymerization by prenylated cellular proteinsThe Journal of cell biology, 1992
- Transplantation of human prostatic carcinoma into nude mice in Matrigel.1991
- v-rasHExpression Confers Hormone-Independentin VitroGrowth to LNCaP Prostate Carcinoma CellsMolecular Endocrinology, 1991
- A nuclear magnetic resonance study of the interactions of the antimalarials chloroquine, quinacrine, quinine and mefloquine with lipids extracted from normal human erythrocytesMolecular and Biochemical Parasitology, 1990
- STRUCTURAL FEATURES DETERMINING ACTIVITY OF PHENOTHIAZINES AND RELATED DRUGS FOR INHIBITION OF CELL-GROWTH AND REVERSAL OF MULTIDRUG RESISTANCE1989
- Phospholipase A2: Function and pharmacological regulationBiochemical Pharmacology, 1987
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984
- Taxol stabilizes microtubules in mouse fibroblast cells.Proceedings of the National Academy of Sciences, 1980
- A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems.Journal of Biological Chemistry, 1977